Congress Epublish
PubMed: 40361346 DOI: 10.3390/cancers17091420
Translating Basic Science Discoveries into Clinical Advances: Highlights from the EACR-AACR-IACR 2024 Conference in Celebration of Irish Association for Cancer Research's 60th Anniversary.
Cancers (Basel) 17(9)
Authors: Seodhna M Lynch, Cathy E Richards, Aisling Ui Mhaonaigh, Niamh Lynam-Lennon, Alex J Eustace, Emma H Allott, Tracy Robson, Simone Marcone
Affiliations
- Personalised Medicine Centre, School of Medicine, Ulster University, C-TRIC Building, Altnagelvin Area Hospital, Glenshane Road, Londonderry BT47 6SB, UK.
- School of Dentistry, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.
- Department of Surgery, Trinity Translational Medicine Institute, Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, D08 NHY1 Dublin, Ireland.
- Department of Biology, Kathleen Lonsdale Institute for Human Health Research, Maynooth University, W23 NPY6 Maynooth, Ireland.
- Life Science Institute, School of Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.
- Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK.
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.
- UCD School of Biology and Environmental Science, University College Dublin, D04 N2E5 Dublin, Ireland.
Abstract
The EACR-AACR-IACR 2024 Basic and Translational Research Conference, held in Dublin, Ireland, from 27th-29th February, 2024, marked a significant milestone as part of the 60th anniversary celebrations of the Irish Association for Cancer Research (IACR). Organized in collaboration with the European Association for Cancer Research (EACR) and the American Association for Cancer Research (AACR), this prestigious event brought together leading experts in oncology research from around the world. The conference provided a platform for cutting-edge discussions on the latest advancements in immunotherapy, drug combinations, cell-based therapies, liquid biopsies, epigenetics, tumour microenvironment, and novel drug targets. With keynote lectures from esteemed researchers such as Kevan Shokat, Jerome Galon, Suzanne Topalian, and Scott Lowe, the conference facilitated knowledge exchange and fostered international collaboration in the pursuit of improved cancer treatments. The report highlights the key sessions, research breakthroughs, and discussions that shaped this landmark event.
MeSH
Pharmaceutical Preparations, Translational Research, Biomedical, Translating, Neoplasms, Drug Therapy, Immunotherapy, Precision Medicine, Research, Therapeutics, Liquid Biopsy